0
Ambien 5mg | LinkedIn www.linkedin.comban site
Ambien 5mg | 2 followers on LinkedIn. Buy Ambien Online | Insomnia (Sleep Onset & Maintenance)nIndicated for insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset)nnImmediate-release tablet, sublingual tablet, and oral spraynDosing for PO (Ambien), SL (Edluar), and oral spray (Zolpimist)nWomen: 5 mg PO/SL/oral spray qHSnMen: Consider 5 mg PO/SL/oral spray qHS; may use 10 mg PO/SL/oral spray qHS if needednExtended-release (Ambien CR)nWomen: 6.25 mg PO qHSnMen: Consider 6.25 mg PO qHS; may use 12.5 mg PO qHS; not to exceed 12.5 mg/daynDosing considerations (Ambien, Ambien CR)nUse lowest effective dose; take only once per night immediately before bedtime with at least 7-8 hr remaining before the planned time of awakeningnIn some patients, higher morning blood levels following use of 10 mg dose increase the risk of next day impairment of driving and other activities that require full alertnessnTotal dose should not exceed 10 mg once daily immediately before bedtime; should be taken as single dose and should not be readministered during same nightnInsomnia (Middle of Night Awakening)nIntermezzo onlynnIndicated for insomnia when a middle of the night awakening is followed by difficulty returning to sleepnnWomen: 1.75 mg SL PRN; not to exceed 1 dose/nightnnMen: 3.5 mg SL PRN; not to exceed 1 dose/nightnnDosing considerations (Intermezzo)nUse only when â¥4 hr of bedtime remain before awakeningnDo not take if alcohol has been consumed or with any other sleep aidnConcomitant with CNS depressants: 1.75 mg SL PRN; not to exceed 1 dose/nightnDosage ModificationsnRenal impairmentnDose adjustment may not be necessary; monitornHepatic impairmentnImmediate-release: 5 mg immediately before bedtimenExtended-release: 6.25 mg immediately before bedtimenSublingual (Edluar): 5 mg immediately before bedtimenSublingual (Intermezzo): 1.75 mg once at night if â¥4 hr remain before awakening
Comments (0)
You need to be logged in to write comments!
This story has no comments.